IRIS
LAZZERINI, PIETRO ENEA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.132
EU - Europa 9.554
AS - Asia 5.727
SA - Sud America 996
AF - Africa 299
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 9
AN - Antartide 1
Totale 28.737
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.938
CN - Cina 1.975
RU - Federazione Russa 1.915
GB - Regno Unito 1.865
SG - Singapore 1.774
IT - Italia 1.290
IE - Irlanda 1.177
BR - Brasile 834
DE - Germania 765
SE - Svezia 715
UA - Ucraina 545
VN - Vietnam 541
FR - Francia 516
HK - Hong Kong 448
FI - Finlandia 388
KR - Corea 312
IN - India 196
ZA - Sudafrica 114
CA - Canada 108
BD - Bangladesh 96
NL - Olanda 75
TR - Turchia 69
ES - Italia 67
AR - Argentina 57
IQ - Iraq 53
CI - Costa d'Avorio 49
MX - Messico 48
PL - Polonia 43
NG - Nigeria 41
JP - Giappone 39
BE - Belgio 38
KE - Kenya 30
EC - Ecuador 29
CZ - Repubblica Ceca 28
AT - Austria 27
PK - Pakistan 25
TH - Thailandia 22
VE - Venezuela 21
CO - Colombia 20
ID - Indonesia 20
GR - Grecia 18
AU - Australia 15
EG - Egitto 14
PH - Filippine 14
TN - Tunisia 14
UZ - Uzbekistan 14
IL - Israele 13
MA - Marocco 13
SA - Arabia Saudita 12
AE - Emirati Arabi Uniti 11
LT - Lituania 11
JO - Giordania 10
KZ - Kazakistan 10
RO - Romania 10
AZ - Azerbaigian 9
CL - Cile 9
JM - Giamaica 9
CH - Svizzera 8
DZ - Algeria 8
IR - Iran 8
NP - Nepal 8
ET - Etiopia 7
EU - Europa 7
KG - Kirghizistan 7
MY - Malesia 7
PY - Paraguay 7
DO - Repubblica Dominicana 6
PE - Perù 6
BG - Bulgaria 5
BO - Bolivia 5
EE - Estonia 5
HR - Croazia 5
HU - Ungheria 5
OM - Oman 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
CR - Costa Rica 4
CY - Cipro 4
HN - Honduras 4
NZ - Nuova Zelanda 4
PA - Panama 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
BY - Bielorussia 3
GY - Guiana 3
LB - Libano 3
SN - Senegal 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BH - Bahrain 2
DK - Danimarca 2
GT - Guatemala 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
MM - Myanmar 2
NI - Nicaragua 2
NO - Norvegia 2
PT - Portogallo 2
Totale 28.705
Salva come PNG Salva come JPEG
Città #
Southend 1.606
Dallas 1.531
Fairfield 1.169
Dublin 1.143
Ashburn 1.027
Singapore 979
Chandler 599
Woodbridge 544
Moscow 537
Santa Clara 518
San Jose 484
Houston 469
Beijing 463
Hefei 436
Seattle 431
Hong Kong 430
Jacksonville 427
Wilmington 424
Cambridge 395
Siena 363
Menlo Park 308
Seoul 305
Ann Arbor 291
Helsinki 237
Princeton 209
The Dalles 208
Los Angeles 177
New York 171
Milan 165
Nanjing 155
Lauterbourg 147
Ho Chi Minh City 144
Dong Ket 125
Council Bluffs 118
Munich 116
Florence 110
Hanoi 110
Johannesburg 101
Boardman 99
Dearborn 94
Buffalo 90
San Diego 80
Vimercate 78
São Paulo 69
San Mateo 65
Nanchang 60
Bengaluru 57
Orem 55
Columbus 50
Shanghai 50
Abidjan 49
Turku 47
Shenyang 44
Brooklyn 43
Chicago 43
London 41
Málaga 40
Frankfurt am Main 39
Toronto 39
Abuja 38
Brussels 36
Redondo Beach 36
Tokyo 34
Changsha 33
Lappeenranta 33
Rome 33
San Francisco 33
Warsaw 33
Amsterdam 31
Denver 29
Poggiomarino 29
Hebei 27
Montreal 27
Nuremberg 27
Phoenix 27
Izmir 26
Lancaster 26
Mumbai 26
Tianjin 26
Düsseldorf 24
Guangzhou 24
Jinan 24
Rio de Janeiro 24
Kunming 23
Belo Horizonte 21
Chennai 21
Jiaxing 21
Norwalk 21
Atlanta 19
Baghdad 19
Da Nang 19
Washington 19
Ankara 18
Boston 18
Fremont 18
Manchester 18
Poplar 18
Pune 18
Stockholm 18
Zhengzhou 17
Totale 19.436
Salva come PNG Salva come JPEG
Nome #
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 420
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 409
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 396
Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation 390
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts 385
Antirheumatic agents in covid-19: is IL-6 the right target? 360
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 358
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 335
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 329
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 316
Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis 313
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 311
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 310
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 299
P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism? 298
Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease 296
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 291
Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection 286
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 284
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 280
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 276
Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti-Ro/Sjögren Syndrome-Related Antigen A Antibodies 273
Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US Veterans 269
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 264
Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs 264
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 260
Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats 259
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 257
Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms 252
Torsades de Pointes in patients with polymyalgia rheumatica 249
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 243
Alteration in the redox state of plasma in heart transplanted patients with moderate hyperhomocisteinemia 243
The role of P2X7 receptors in tissue fibrosis: a brief review 241
Levels of circulating CXCR4-positive cells are decreased and negatively correlated with risk factors in cardiac transplant recipients 239
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 239
Simvastatin inhibits T cell activation by selectively impairing the function of RAS superfamily GTPases 238
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 233
Cardiac arrest risk during acute infections: systemic inflammation directly prolongs QTc interval via cytokine-mediated effects on potassium channel expression 233
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls 233
Human rheumatoid synoviocytes express functional P2X7 receptors 230
The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols 230
Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis 230
Arrhythmogenic effects of anti-Ro/SSA antibodies on theadult heart: more than expected? 230
Neutrophil extracellular traps release in gout and pseudogout depends on the number of crystals regardless of leukocyte count 230
Statins and the joint: multiple targets for a global protection? 227
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 225
Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses 224
Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad 222
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 220
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 219
Le indicazioni al trattamento con immunoglobuline endovena nelle malattie reumatiche. [Indications for intra-venous immunoglobulin treatment in rheumatic diseases] 219
Connective tissue diseases and cardiac rhythm disorders: an overview 217
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 212
Atrial cardiopathy and sympatho-vagal imbalance in cryptogenic stroke: Pathogenic mechanisms and effects on electrocardiographic markers 212
T lymphocytes as targets of statins: molecular mechanisms and therapeutic perspectives 208
SEX HORMONES IN LONG QT SYNDROME AND TORSADES DE POINTES (TDP) 207
Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients. 201
Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: Clinical evidence, putative mechanisms, and therapeutic implications 199
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 199
The "Invulnerability" of the Adult Conduction System to Anti-Ro/SSA Antibodies? A Matter of Calcium Channel Expression on the Cardiomyocyte 199
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 197
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 197
Pathogenesis of the novel autoimmune-associated long-QT syndrome 197
How to Identify Patients at Risk of Silent Atrial Fibrillation after Cryptogenic Stroke: Potential Role of P Wave Dispersion 196
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 196
Previous use of statins and atrial electrical remodeling in patients with cryptogenic stroke 191
Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias 188
Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies 187
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation 187
Elevated Interleukin-6 Levels Are Associated With an Increased Risk of QTc Interval Prolongation in a Large Cohort of US Veterans 186
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts 182
Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies 181
Simvastatin reduces MMP-3 level in interleukin 1b-stimulated human chondrocyte culture 177
Urinary tract infections caused by Gram-negative bacteria in elderly hospitalized patients: epidemiology, clinical features and outcomes in the era of antimicrobial resistance 176
Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk 176
P wave dispersion and silent atrial fibrillation in cryptogenic stroke: The pathogenic role of inflammation 176
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 173
Photopheresis immunomodulation after heart transplantation. 173
Blunted increase in plasma adenosine levels following dipyridamole stress test in dilated cardiomyopathy patients 172
Long QT Syndrome: An Emerging Role for Inflammation and Immunity 170
Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities 170
Interleukin-6 elevation Is a key pathogenic factor underlying COVID-19-associated heart rate-corrected QT interval prolongation 168
Homocysteine and Raynaud’s phenomenon: a review 167
Clinically-relevant cyclosporin and rapamycin concentrations enhance regulatory T cell function to a similar extent but with different mechanisms: An in-vitro study in healthy humans. 165
Comment on: Letter to the Editor from Clockaerts and Bierma-Zeinstra 164
Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. 164
Potassium Channel Block and Novel Autoimmune-Associated Long QT Syndrome 163
Comment on “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?” 161
Statins as a new therapeutic perspective in myocarditis and postmyocarditis dilated cardiomyopathy 160
Inhibitory effect of synthetic cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes 160
Homocysteine and P wave dispersion in patients with heart transplantation 158
Corrected QT interval in anti-SSA-positive adults with connective tissue disease: Comment on the article by Lazzerini et al. [6] (multiple letters) 155
Increased interleukin-6 levels are associated with atrioventricular conduction delay in severe COVID-19 patients 154
Editorial: Insights in general cardiovascular medicine: 2022 150
Simvastatin inhibits cytokine production and nuclear factor-kB activation in interleukin 1beta-stimulated synoviocytes from rheumatoid arthritis patients 148
Hyperhomocysteinemia: a cardiovascular risk factor in autoimmunediseases? 148
Risk of qtc interval prolongation associated with circulating anti-ro/ssa antibodies among us veterans: an observational cohort study 146
Hyperhomocysteinemia, inflammation and autoimmunity 143
null 141
Electrocardiographic Predictors of Silent Atrial Fibrillation in Cryptogenic Stroke 141
Totale 22.795
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.516
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.516
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021216 0 0 0 0 0 0 0 0 0 0 0 216
2021/20221.894 135 220 91 146 130 55 91 146 142 167 196 375
2022/20232.267 144 244 310 318 179 435 78 160 228 65 60 46
2023/20241.995 69 39 149 100 94 534 607 61 33 46 78 185
2024/20254.348 89 201 365 256 491 276 197 273 347 214 442 1.197
2025/202610.071 860 1.579 1.046 1.218 1.821 464 1.210 300 373 587 433 180
Totale 29.200